PVCT Provectus Biopharmaceuticals - Oral RB and its effect on IL6. Questions for the AM. - PVCT Provectus Biopharmaceuticals - InvestorVillage


PVCT Provectus Biopharmaceuticals
  •  
    As promised, anyone interested can click this link to view the survey results and read some of our initial takeaways from the data collected. Thanks again to all who participated! 
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: PVCT Provectus Biopharmaceuticals   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  5979 of 5990  at  6/11/2021 12:04:01 AM  by

leave_the_gun


Oral RB and its effect on IL6. Questions for the AM.

https://en.m.wikipedia.org/wiki/Interleukin_6
 
IL-6 stimulates the inflammatory and auto-immune processes in many diseases such as Multiple sclerosis,[46] Neuromyelitis Optica Spectrum Disorder (NMOSD),[46] diabetes,[47] atherosclerosis,[48] depression,[49] Alzheimer's Disease,[50] systemic lupus erythematosus,[51] multiple myeloma,[52] prostate cancer,[53] Behçet's disease,[54] rheumatoid arthritis,[55] and intracerebral hemorrhage.[56]

Everyone that attends the Annual Meeting needs to ask about oral RB and its effect of down regulating IL6. I have a feeling they'll answer these questions.

If you recall the PH-10 presentations and then the patent application, Per Dr Kruger, PH-10 down regulated IL17, 23 and others. What he did not say is that it also down regulates IL6. Because you can’t down regulate IL17, 23 without affecting IL6.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135960/

https://pubmed.ncbi.nlm.nih.gov/22652781/

https://www.karger.com/article/FullText/484390

https://www.frontiersin.org/articles/10.3389/fimmu.2018.01682/full

https://rupress.org/jem/article/206/7/1457/40324/IL-17-can-promote-tumor-growth-through-an-IL-6

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539212/

To me, PH-10 research opened up a ton of new science inhibition of IL6, 17, 23 related to numerous diseases. That patent request was packet full of information and data that most likely got a lot of minds thinking. And now we’re hearing about oral RB.  Hmm…

PV-10 is probably only a portion of PVCT’s worth.
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 7     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
5980 Re: Oral RB - effect on IL6....Can BPs even get there head around the implicatons? Take_The_Canolis 6 6/11/2021 11:26:37 AM


Financial Market Data provided by
.
Loading...